Quick Answer
Quoin Pharmaceuticals, Ltd. reported Cash And Cash Equivalents At Carrying Value of $3.82 million for the year ending 2025.
- Quoin Pharmaceuticals, Ltd. showed an increase of +5.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Quoin Pharmaceuticals, Ltd.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Quoin Pharmaceuticals, Ltd.'s Cash And Cash Equivalents At Carrying Value has grown by 1,079.0%.
- Historical annual values: Fiscal year 2025: $3.82 million | Fiscal year 2024: $3.62 million | Fiscal year 2023: $2.40 million | Fiscal year 2022: $2.86 million | Fiscal year 2021: $7.48 million | Fiscal year 2020: $323.8 thousand.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: